New York City officials said in 2024 they, too, were dropping coverage for weight-loss drugs after reportedly saying they had been paying for them in error . More than 40,000 customers of Massachusetts two biggest insurers, Blue Cross and Point32Health, have lost coverage of GLP-1s for obesity this year, according to the data the companies provided to the Globe
Family members or caregivers can also provide valuable support by offering gentle reminders or helping establish accountability systems
Improved microbiota composition may further enhance semaglutides efficacy and tolerability by lowering gut-derived inflammation, thus potentially optimising GLP-1 analogue action (Fig
These drugs are more effective than prior available medications in that they directly target hormones that help the patient feel less hungry and more full for a longer period, he explained
Wegovy PI
Int J Diabetes Technol 2023;2:7984